T. Rowe Price Associates’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,907,436
Closed -$114M 2653
2020
Q2
$114M Buy
1,907,436
+100,008
+6% +$6.18M 0.01% 599
2020
Q1
$107M Buy
1,807,428
+251,656
+16% +$14.7M 0.02% 555
2019
Q4
$85.2M Buy
1,555,772
+639,994
+70% +$23.9M 0.01% 714
2019
Q3
$25.9M Sell
915,778
-7,174
-0.8% -$263K ﹤0.01% 1079
2019
Q2
$30.6M Buy
922,952
+8,970
+1% +$280K ﹤0.01% 1039
2019
Q1
$31.1M Buy
913,982
+2,010
+0.2% +$63.9K ﹤0.01% 1033
2018
Q4
$25M Buy
911,972
+44,913
+5% +$1.16M ﹤0.01% 1076
2018
Q3
$25.3M Buy
+867,059
New +$24.5M ﹤0.01% 1142

Other funds holding PRNB